What is the latest DRREDDY stock price?
The latest stored price for DRREDDY is Rs 1,174.70 as of 2026-08-21.
gimli
DRREDDY stock AI analysis
DRREDDY Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
DR. REDDY S LABORATORIES is a large-cap stock in Healthcare. This Gimli page shows the latest available DRREDDY price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹1,174.70
1W return
-2.11%
1M return
-2.60%
3M return
-10.91%
6M return
-8.26%
1Y return
-7.98%
Market cap
₹97,804.91 cr
PE
29.54
PB
2.53
ROE
+9.23%
ROCE
+10.80%
RSI
43.08
Turnover
₹146.46 cr
Why it can matter in screens
- Momentum: DRREDDY is below 50DMA, below 200DMA; RSI is 43.08.
- Returns: 1D -0.45%, 1W -2.11%, 1M -2.60%, 3M -10.91%, 1Y -7.98%.
- Trend levels: 52W high ₹1,414.90, 52W low ₹1,101.00, off high -16.98%.
- Liquidity: latest turnover is ₹146.46 cr; volume vs 20D is +0.73%.
- Valuation/profitability: PE 29.54, PB 2.53, ROE +9.23%, ROCE +10.80%.
- Growth: 3Y sales CAGR +10.96%, 3Y profit CAGR -1.67%.
Quick Answers
Is DRREDDY above its 50DMA and 200DMA?
DRREDDY is below 50DMA, below 200DMA. The latest 50DMA is 1,236.47 and the latest 200DMA is 1,255.60.
What are DRREDDY PE, ROE and ROCE?
DRREDDY has PE 29.54, ROE +9.23%, and ROCE +10.80% in Gimli's latest available snapshot.
How has DRREDDY performed recently?
DRREDDY has returned -2.60% over 1 month, -10.91% over 3 months, and -7.98% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 8,070.50 cr | 1,215.30 cr | 443.50 cr | 5.32 |
| 2026-03-31 | 7,516.20 cr | 863.00 cr | 220.90 cr | 2.65 |
| 2025-12-31 | 8,726.80 cr | 2,158.60 cr | 1,209.80 cr | 14.53 |
| 2025-09-30 | 8,805.10 cr | 2,430.80 cr | 1,437.20 cr | nan |
| 2025-06-30 | 8,545.20 cr | 2,464.20 cr | 1,417.80 cr | 17.04 |
| 2025-03-31 | 8,506.00 cr | 2,526.20 cr | 1,593.30 cr | 19.12 |
| 2024-12-31 | 8,358.60 cr | 2,427.90 cr | n/a | 16.96 |
| 2024-09-30 | 8,016.20 cr | 2,389.90 cr | n/a | nan |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 33,593.30 cr | 7,916.00 cr | 4,285.00 cr | 51.48 |
| 2025-03-31 | 32,553.50 cr | 9,667.10 cr | 5,654.40 cr | 67.89 |
| 2024-03-31 | 27,916.40 cr | 8,842.20 cr | 5,568.40 cr | 67.04 |
| 2023-03-31 | 24,587.90 cr | 7,443.10 cr | 4,506.70 cr | 54.29 |
| 2022-03-31 | 14,887.20 cr | 4,508.00 cr | 1,623.20 cr | 97.58 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 57,934.60 cr | 1,536.80 cr | 7,734.10 cr | 38,045.70 cr |
| 2025-03-31 | 49,298.90 cr | 1,465.40 cr | 4,676.60 cr | 33,716.60 cr |
| 2024-03-31 | 38,751.80 cr | 710.70 cr | 2,002.00 cr | 28,055.00 cr |
| 2023-03-31 | 32,185.40 cr | 577.90 cr | 1,347.20 cr | 23,099.10 cr |
| 2022-03-31 | 29,282.70 cr | 1,485.20 cr | 3,384.50 cr | 19,052.70 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 5,675.50 cr | 1,833.00 cr | n/a |
| 2025-03-31 | 4,642.80 cr | 1,203.00 cr | n/a |
| 2024-03-31 | 4,543.30 cr | 1,799.80 cr | n/a |
| 2023-03-31 | 5,887.50 cr | 4,000.90 cr | n/a |
| 2022-03-31 | 2,810.80 cr | 905.90 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +26.64% | +32.07% | +31.74% | +13.16% | +9.35% | +0.00% |
| 2026-03-31 | +26.63% | +33.08% | +30.72% | +13.19% | +9.33% | +0.00% |
| 2025-12-31 | +26.64% | +33.20% | +30.44% | +13.87% | +9.47% | +0.00% |
| 2025-09-30 | +26.64% | +35.52% | +27.98% | +13.31% | +9.61% | +0.00% |
| 2025-06-30 | +26.64% | +36.36% | +26.74% | +13.61% | +10.00% | +0.00% |
| 2025-03-31 | +26.64% | +37.29% | +25.62% | +12.89% | +10.15% | +0.00% |
| 2024-12-31 | +26.64% | +40.08% | +22.90% | +11.14% | +10.22% | +0.00% |
| 2024-09-30 | +26.64% | +41.75% | +21.48% | +10.86% | +9.97% | +0.00% |
| 2024-06-30 | +26.65% | +42.27% | +20.73% | +10.05% | +10.19% | +0.00% |
| 2024-03-31 | +26.65% | +44.49% | +18.31% | +7.96% | +10.38% | +0.00% |
| 2023-12-31 | +26.65% | +43.96% | +18.65% | +8.22% | +10.57% | +0.00% |
| 2023-09-30 | +26.66% | +42.21% | +21.04% | +8.61% | +9.91% | +0.00% |
| 2023-06-30 | +26.69% | +39.54% | +21.99% | +9.31% | +11.57% | +0.00% |
| 2023-03-31 | +26.70% | +38.55% | +23.05% | +9.87% | +11.48% | n/a |
| 2022-12-31 | +26.70% | +37.82% | +23.38% | +10.94% | +11.84% | +0.00% |
| 2022-09-30 | +26.71% | +36.34% | +24.70% | +12.84% | +11.99% | +0.00% |
| 2022-06-30 | +26.71% | +0.00% | +51.05% | n/a | n/a | n/a |
| 2022-03-31 | +26.72% | +0.00% | +49.94% | n/a | n/a | +0.00% |
| 2021-12-31 | +26.72% | +0.00% | +49.71% | n/a | n/a | n/a |
| 2021-09-30 | +26.72% | +0.00% | +49.16% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 456,449.49 cr | 37.677543 | +15.50% | +15.99% |
| DIVISLAB | DIVI S LABORATORIES LTD | 228,223.36 cr | 78.319614 | +18.37% | +42.62% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 165,719.79 cr | 75.983398 | +17.33% | +34.25% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 124,992.04 cr | 63.823550 | +21.03% | +9.67% |
| CIPLA | CIPLA LTD | 115,693.19 cr | 34.304976 | +10.25% | -10.08% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 112,698.21 cr | 22.474914 | +17.93% | +13.61% |
| LUPIN | LUPIN LIMITED | 100,669.80 cr | 14.727517 | +34.34% | +12.19% |
| MANKIND | MANKIND PHARMA LIMITED | 98,418.27 cr | 47.977550 | +13.18% | -8.31% |
Try these prompts
- Analyze DR. REDDY S LABORATORIES with valuation, momentum and industry peers
- Compare DRREDDY with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare DRREDDY with other Healthcare stocks
Data snapshot: 2026-08-21. Not investment advice.